GNR-060 (tenecteplase biosimilar)
/ Generium
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
September 22, 2026
Study of Efficacy and Safety of GNR-060 vs Metalyse in Patients With ST Elevation Myocardial Infarction
(clinicaltrials.gov)
- P3 | N=244 | Completed | Sponsor: AO GENERIUM | Recruiting ➔ Completed
Trial completion • Cardiovascular • Myocardial Infarction
March 06, 2024
Study of Efficacy and Safety of GNR-060 vs Metalyse in Patients With ST Elevation Myocardial Infarction
(clinicaltrials.gov)
- P3 | N=244 | Recruiting | Sponsor: AO GENERIUM | Trial completion date: Dec 2023 ➔ Oct 2024 | Trial primary completion date: Sep 2023 ➔ Oct 2024
Trial completion date • Trial primary completion date • Cardiovascular • Myocardial Infarction
November 01, 2022
Study of Efficacy and Safety of GNR-060 vs Metalyse in Patients With ST Elevation Myocardial Infarction
(clinicaltrials.gov)
- P3 | N=244 | Recruiting | Sponsor: AO GENERIUM
New P3 trial • Cardiovascular • Myocardial Infarction
1 to 3
Of
3
Go to page
1